Research Article
Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
Table 3
Secondary outcome measure after 12-month treatment and 6-month followup after study drugs terminated.
| | Secondary endpoints | 12-month treatment completed | 18-month followup accomplished | | QSYQ () | Aspirin () | HR (95% CI) | QSYQ () | Aspirin () | HR (95% CI) |
| | Revascularization | 21 (1.20%) | 18 (1.02%) | 1.18 (0.63, 2.20) | 23 (1.32%) | 26 (1.48%) | 0.89 (051, 1.56) | | Aggravated heart failure | 20 (1.15%) | 23 (1.31%) | 0.88 (0.48, 1.59) | 28 (1.60%) | 28 (1.59%) | 1.01 (0.60, 1.69) | | Cardiac shock | 1 (0.06%) | 1 (0.06%) | 1.01 (0.06, 16.09) | 1 (0.06%) | 2 (0.11%) | 0.50 (0.05, 5.55) | | Deep vein thrombosis | 0 (0) | 1 (0.06%) | — | 0 (0) | 2 (0.11%) | — |
| | Sum up | 42 (2.41%) | 43 (2.44%) | 0.98 (0.65, 1.50) | 52 (2.98%) | 58 (3.30%) | 0.90 (0.62, 1.31) |
|
|
